Study ID: TV48125-CNS-30049 | 2015-004549-23
Study Title
- Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
Teva Identifier
- TV48125-CNS-30049 | 2015-004549-23
ClinicalTrials.gov Identifier
- NCT02621931
Study Status
- Completed
Trial Condition(s)
- Migraine
Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- March 22, 2016 - April 11, 2017
Phase
- Phase 3
Study Type
Interventional